Patient, Defect, and Surgical Factors Influencing Use of Ancillary Procedures after Facial Mohs Repairs.


Journal

Facial plastic surgery : FPS
ISSN: 1098-8793
Titre abrégé: Facial Plast Surg
Pays: United States
ID NLM: 8405303

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 29 1 2021
medline: 4 6 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

This article determines if patient, defect, and repair factors can be used to predict the use of additional treatments to achieve optimal aesthetic results after repair of facial Mohs defects. An electronic chart review of patients undergoing Mohs excision and reconstruction of facial neoplasms from November 2005 to April 2017 was performed, reviewing patient demographics and history, tumor size, defect size and location, method and service of reconstruction, time between resection and repair, complications, and subsequent treatments. A total of 1,500 cases with basal cell and squamous cell carcinoma were analyzed. The average defect size was 3.09 ± 8.06 cm

Identifiants

pubmed: 33506452
doi: 10.1055/s-0040-1721100
doi:

Types de publication

Journal Article

Langues

eng

Pagination

390-394

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Romy A Neuner (RA)

Department of General Surgery, Spital Uster, Uster, Switzerland.

Anthony P Sclafani (AP)

Department of Otolaryngology - Head & Neck Surgery, Joan and Sanford I Weill Medical College of Cornell University, New York, New York.
Department of Facial Plastic & Reconstructive Surgery, Center for Facial Plastic Surgery, Chappaqua, New York.

Kira Minkis (K)

Department of Dermatology, Weill Cornell Medical College, New York, New York.

Ade Obayemi (A)

Department of Otolaryngology - Head and Neck Surgery, NewYork-Presbyterian Hospital, New York, New York.

Kristina Navrazhina (K)

Department of Dermatology, Weill Cornell Medical College, New York, New York.

Brienne Cressey (B)

Northeast Dermatology Associates, Dover, New Hampshire.

Sam Ojeda (S)

Massachusetts General Hospital Cancer Center, Center for Cancer Research, Charlestown, Massachusetts.

Oscar Trujillo (O)

Department of Otolaryngology, Columbia University, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH